Old Mission Capital LLC Genetic Technologies LTD Transaction History

Old Mission Capital LLC

  • $3.51 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023
SELL
$0.86 - $1.82 $41,822 - $88,508
-48,631 Reduced 69.23%
21,610 $25,000
Q4 2022

Feb 14, 2023
BUY
$0.93 - $6.18 $34,170 - $227,065
36,742 Added 109.68%
70,241 $65,000
Q3 2022

Nov 14, 2022
BUY
$0.0 - $6.4 $0 - $214,393
33,499 New
33,499 $39,000

About GENETIC TECHNOLOGIES LTD

GENE Quotes by TradingView
  • Ticker GENE
  • Exchange OTC
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 15,389,900
  • Market Cap $11.9M
  • Description
  • Genetic Technologies Limited, a molecular diagnostics company, provides predictive testing and assessment tools to help physicians manage women's health in Australia and the United States. The company's lead product is the BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer. It also markets BREVAGenplus to ...
More about GENE
Track This Portfolio

Track Old Mission Capital LLC Portfolio

Follow Old Mission Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Old Mission Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Old Mission Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email